A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave researchers a look at how primary ...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, ...

But two-year funding for a new type of surgery in Wales - which until that point was only available elsewhere in the UK - ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

The role of oncology nurses and APPs in research is largely to stay abreast of trials that may be useful to patients and recommend them whenever possible, according to Erica Doubleday, MS, FNP-C, BSN, ...

A brain cancer patient has been left "confused" and "shattered" after learning he took chemotherapy drugs needlessly for more ...

An app to replace paper hospital passports has been created by a group of patients aiming to make hospital visits easier. The ...

A screening tool was effective in identifying abuse among young children with a single bruise in a pediatric emergency ...

Police could charge two nurses with a carriage service offence after suggesting they would harm or "kill" Israeli patients ...